Inicio / Estudios Omega-3 / 5. Bibliograf�a en menopausia


5. Bibliograf�a en menopausia


5.1 EPA y DHA y prevenci�n del c�ncer de mama

Maillard V, Bougnoux P, Ferrari P, Jourdan ML, Pinault M, Lavillonni�re F, Body G, Le Floch O, Chaj�s V.. n-3 and n-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Int J Cancer. 2002;98:78-83.
Badawi AF, El-Sohemy A, Stephen LL, Ghoshai AK, Archer MC. Carcinogenesis. 1998;19:903-10.
Bartsch H, Nair J, Owen RW. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 1999; 20: 2209-18.
Goodstine SL, Zheng T, Holford TR, Ward BA, Carter D, Owens PH, Mayne ST. Dietary (n-3)/(n-6) fatty acid ratio: possible relationship to premenopausal but not to post-menopausal breast cancer risk in US women. J Nutr. 2003;133:1409-14.
Jump DB, Clarke SD, Thelen A, Liimatta M, Ren B, Badin MV. Dietary fat, genes and human health. Med Biol 1997;422:167-76.
Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004; 79: 935-45.
Platet N, Prevostel C, Derocq D, Joubert D, Rochefort H, Garc�a M. Breast cancer cell invasiveness: correlation with PKCactivity and differential regulation by phorbol ester in ER positive and negative cells. Int J Cancer. 1998; 75:750-6.
Rose DP, Connolly JM, Coleman M. Effect of n-3 fatty acids on the progression pf metastases after excision of human breast cancer cell solid tumors growing in nude mice. Clin Cancer Res. 1996;2:1751-6.
Stoll BA. n-3 fatty acids and lipid peroxidation in breast cancer inhibition. Br J Nutr 2002; 87:193-198.
5.2 EPA y DHA s�ntomas climat�ricos y depresi�n

Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 1993; 5: 123-33.
Hibbein JR, Ferguson TA, Blasbalg TL. Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: opportunities for intervention. Int Rev Psychiatry. 2006;18:107-18.
Irmish G, Schl�fke D, Gierow W, Herpertz S, Richter J. Fatty acids and sleep in depressed inpatients. Prostaglandins Leuk Essent Fatty Acids. 2007;76:1-7.
Lin PY, Su, KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68:1056-61.
Lucas M, Asselin G, M�rette C, Poulin MJ, Dodin S. Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: A double-blind, placebo-controlled, randomized clinical trial. Menopause 2009;16(2):357-66.
Marszalek JR, Lodish HF. Docosahexaenoic acid, fatty acid-interacting proteins and neural function. Annual Review of Cell and Development Biology 2005; 21: 633-657.
McNamara RK, Hahn CG, Jandacek R, Rider T, Tso P, Stanford KE, Richtand NM. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the post-mortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007; 62: 17-24.
Monterrosa A. �Qu� hacer en la atenci�n primaria de la mujer en menopausia y climaterio? Med UNAB. 2005;8:137-46.
Monterrosa A. 1500 recomendaciones y aseveraciones nutricionales para las mujeres en menopausia. Cartagena, 2005 (en prensa).
Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159:477-9.
Parker G, Gibson NA, Brotchie H, Heruc G, Rees AMHadzi-Pavlovic D. Omega-3 fatty acids and mood disorders. Am J Psychiatry. 2006;163:969-78.
Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56:407-12.






 
  • Entidades colaboradoras: